Astria Therapeutics Inc.
(ATXS)
undefined
undefined%
At close: undefined
9.52
0.21%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | - | - | - | - | - | - | 500.00K | - | - | - | - | - |
Cost of Revenue | - | - | - | - | 26.00K | 119.00K | - | 395.00K | 202.00K | - | - | - |
Gross Profit | - | - | - | - | -26.00K | -119.00K | 500.00K | -395.00K | -202.00K | - | - | - |
Operating Income | -83.03M | -53.50M | -194.98M | -37.44M | -27.09M | -26.37M | -27.09M | -35.56M | -31.66M | -21.68M | -18.12M | -15.67K |
Interest Income | 10.20M | 1.72M | 122.00K | 236.00K | 845.00K | 425.00K | 160.00K | 242.00K | - | - | - | 4.00 |
Pretax Income | -72.89M | -51.83M | -194.91M | -37.30M | -26.29M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M | -18.12M | -15.67K |
Net Income | -72.89M | -50.16M | -30.17M | -37.06M | -26.24M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M | -18.12M | -15.67K |
Selling & General & Admin | 25.70M | 19.24M | 14.81M | 11.85M | 8.77M | 9.33M | 8.91M | 10.11M | 8.63M | 6.00M | 4.13M | 3.98K |
Research & Development | 57.33M | 34.26M | 15.55M | 25.59M | 18.32M | 17.04M | 18.68M | 25.45M | 23.03M | 15.69M | 13.99M | 12.41K |
Other Expenses | - | -55.00K | -58.00K | -101.00K | -50.00K | 176.00K | 32.00K | 93.00K | 7.00K | 3.00K | 1K | - |
Operating Expenses | 83.03M | 53.50M | 30.36M | 37.44M | 27.09M | 26.37M | 27.59M | 35.56M | 31.66M | 21.68M | 18.12M | 15.67K |
Interest Expense | - | - | - | - | - | 100.00K | 462.00K | 837.00K | 978.00K | 206.00K | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | 718.00 |
Cost & Expenses | 83.03M | 53.50M | 30.36M | 37.44M | 27.09M | 26.37M | 27.59M | 35.56M | 31.66M | 21.68M | 18.12M | 15.67K |
Income Tax | - | -1.67M | -164.74M | -236.00K | -50.00K | 601.00K | 494.00K | 930.00K | 783.00K | 209.00K | - | - |
Shares Outstanding (Basic) | 30.12M | 14.62M | 8.93M | 3.06M | 1.87M | 842.47K | 361.36K | 270.50K | 134.03K | 144.42K | 144.42K | 144.42K |
Shares Outstanding (Diluted) | 30.12M | 14.62M | 8.93M | 3.06M | 1.87M | 842.47K | 361.36K | 270.50K | 134.03K | 144.42K | 144.42K | 144.42K |
EPS (Basic) | -2.42 | -3.43 | -3.38 | -12.12 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 | -125.45 | -0.11 |
EPS (Diluted) | -2.42 | -3.43 | -3.38 | -12.12 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 | -125.45 | -0.11 |
EBITDA | -83.03M | -53.50M | -194.98M | -37.44M | -26.27M | -25.65M | -26.60M | -34.83M | -31.46M | -21.43M | -17.80M | -15.34M |
Depreciation & Amortization | -15.20M | 228.49K | -164.62M | 26.00K | 26.00K | 119.00K | 304.00K | 395.00K | 202.00K | 248.00K | 320.00K | 327.00 |